Olubukola Ayodele: Addressing the mechanism of Endocrine Resistance in HR+ metastatic breast cancer patients at ESMO 2024

Olubukola Ayodele shared on Linkedin:

“I’m thrilled to share that my friend Abeid M. Athman Omar achieved the honor of winning the best poster today for his incredible work focusing on ‘Addressing the mechanism of Endocrine Resistance in HR+/HER2- HRD positive metastatic breast cancer patients’ at ESMO 2024.

This is truly a fantastic achievement!”

Source: Olubukola Ayodele/Linkedin

Dr. Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, specializing in breast and genitourinary malignancies, including germ cell tumors. She is also an honorary Senior Lecturer at the University of Leicester and heads the Breast Cancer Clinical Trials Unit at the Leicester Cancer Research Centre. Dr. Ayodele’s work includes numerous publications, clinical trials, and collaborative research projects on molecular drivers and biomarkers in breast cancer. She is a member of ASCO, ESMO, ACP and UKBCG.